Reproductive endocrinology: Infertility treatment in PCOS-is metformin in from the cold?

Nature Reviews Endocrinology

Volumn 8, Issue 6, 2012, Pages 328-330

  Diamanti Kandarakis, Evanthia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CLOMIFENE CITRATE; GONADOTROPIN; METFORMIN; PLACEBO;

ANOVULATION; BODY MASS; DRUG EFFICACY; DRUG SAFETY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GESTATIONAL AGE; GLUCOSE INTOLERANCE; HUMAN; HYPERANDROGENISM; INFERTILITY THERAPY; INSULIN RESISTANCE; INTENTION TO TREAT ANALYSIS; INTRACYTOPLASMIC SPERM INJECTION; LIFESTYLE MODIFICATION; LIVE BIRTH; MULTICENTER STUDY (TOPIC); OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PHENOTYPE; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT SURVEY; TREATMENT DURATION; WEIGHT REDUCTION;

COMORBIDITY; FEMALE; HUMANS; INFERTILITY, FEMALE; METFORMIN; OBESITY; POLYCYSTIC OVARY SYNDROME; TREATMENT OUTCOME;

EID: 84861333618     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2012.69     Document Type: Short Survey

References (10)

1. Morin-Papunen, L. et al. Metformin improves pregnancy and live-birth rates in women with polycystic ovary syndrome (PCOS): a multicenter, double-blind, placebo-controlled randomized trial. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2011-3061.
2. Nader, S. Infertility and pregnancy in women with polycystic ovary syndrome. Minerva Endocrinol. 35, 211-225 (2010).
3. Fauser B. C. et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil. Steril. 97, 28-38.e25 (2012).
4. Desilets, A. R., Dhakal-Karki, S. & Dunican, K. C. Role of metformin for weight management in patients without type 2 diabetes. Ann. Pharmacother. 42, 817-826 (2008). (Pubitemid 351778088)
5. Glueck, C. J. et al. Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy. Eur. J. Obstet. Gynecol. Reprod. Biol. 122, 206-212 (2005). (Pubitemid 41430458)
6. Boots, C. & Stephenson, M. D. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin. Reprod. Med. 29, 507-513 (2011).
7. Pasquali, R. et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 85, 2767-2774 (2000). (Pubitemid 32269149)
8. Gennarelli, G. et al. Prediction models for insulin resistance in the polycystic ovary syndrome. Hum. Reprod. 15, 2098-2102 (2000).
9. Diamanti-Kandarakis, E. & Panidis, D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin. Endocrinol. (Oxf.) 67, 735-742 (2007). (Pubitemid 47620439)
10. Palomba, S. et al. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response. Hum. Reprod. 25, 1005-1013 (2010).